Stein Gold, Linda, Kilian Eyerich, Howard Sofen, Pedro Herranz, Leon Kircik, Tony Bewley, Eric Wolf, Gaia Gallo, Yuxin Ding, Fan Emily Yang, Ignasi Pau-Charles, and Melinda Gooderham. 2023. “Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity”. SKIN The Journal of Cutaneous Medicine 7 (6):s274. https://doi.org/10.25251/skin.7.supp.274.